86 related articles for article (PubMed ID: 20726323)
41. Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factor.
Mazur G; Butrym A; Kryczek I; Dlubek D; Jaskula E; Lange A; Kuliczkowski K; Jelen M
PLoS One; 2014; 9(5):e98194. PubMed ID: 24859274
[TBL] [Abstract][Full Text] [Related]
42. Increased frequency of circulating Th22 cells in patients with B-cell non-Hodgkin's lymphoma.
Lu T; Liu Y; Yu S; Yin C; Li P; Ye J; Ma D; Ji C
Oncotarget; 2016 Aug; 7(35):56574-56583. PubMed ID: 27489357
[TBL] [Abstract][Full Text] [Related]
43. A20 promoted the phagocytosis of lymphoma cells by dendritic cells from activated B-cell-like non-Hodgkin lymphoma.
Ha NT; Trang DT; Nhat PV; Huong PT; Giang NH; Mao CV; Binh VD; Vuong NB; Xuan NT
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):1-9. PubMed ID: 38814241
[TBL] [Abstract][Full Text] [Related]
44. The usefulness of in vivo gene expression investigations from peripheral white blood cells: a preliminary study.
Ember I; Kiss I; Raposa T
Eur J Cancer Prev; 1999 Aug; 8(4):331-4. PubMed ID: 10493309
[TBL] [Abstract][Full Text] [Related]
45. CD40-activated B cell cancer vaccine improves second clinical remission and survival in privately owned dogs with non-Hodgkin's lymphoma.
Sorenmo KU; Krick E; Coughlin CM; Overley B; Gregor TP; Vonderheide RH; Mason NJ
PLoS One; 2011; 6(8):e24167. PubMed ID: 21904611
[TBL] [Abstract][Full Text] [Related]
46. Isolation and characterization of spontaneously immortalized B-lymphocyte lines from HIV-infected patients with and without non-Hodgkin's Lymphoma.
Zhuang K; Zhang Y; Zhou L; Qi X; Xu X; Meng F; Xu Z; Liu J; Shao L; Liu H; Liu H; Fang J; Deng D; Peng J; Zhou F; Liu L; Tang H; Xiong Y; Ho W; Guo D; Ke H; Gui X
Cancer Med; 2019 Nov; 8(15):6741-6755. PubMed ID: 31538749
[TBL] [Abstract][Full Text] [Related]
47. In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma.
Shamash J; Salam AH; Davies DC; Williams A; Joel S; Lister TA
Br J Cancer; 1998 May; 77(10):1598-603. PubMed ID: 9635834
[TBL] [Abstract][Full Text] [Related]
48. Lymphocyte urosynthase in non-Hodgkin's lymphoma. An indicator of disease extensiveness.
Inbal A; Modan M; Weitz Z; Lahav M; Schoenfeld N; Atsmon A; Shaklai M
Cancer; 1987 Jan; 59(1):89-93. PubMed ID: 3791149
[TBL] [Abstract][Full Text] [Related]
49. IL-9 contributes to immunosuppression mediated by regulatory T cells and mast cells in B-cell non-hodgkin's lymphoma.
Feng LL; Gao JM; Li PP; Wang X
J Clin Immunol; 2011 Dec; 31(6):1084-94. PubMed ID: 21898141
[TBL] [Abstract][Full Text] [Related]
50. Malignant lymphocytic lymphoma. Demonstration of a serum inhibitor of myelopoiesis and response to combination chemotherapy.
Balentine L; Skikne BS; Park CH; Lynch SR
Cancer; 1983 Jul; 52(1):35-8. PubMed ID: 6221789
[TBL] [Abstract][Full Text] [Related]
51. Monoclonal B cells in peripheral blood in non-Hodgkin's lymphoma. Correlation with clinical features and DNA content.
Lindh J; Lenner P; Roos G
Scand J Haematol; 1984 Jan; 32(1):5-11. PubMed ID: 6607509
[TBL] [Abstract][Full Text] [Related]
52. Expression of PD-1 on peripheral blood Treg cells is related to the diagnosis, prognosis and treatment of T cell non-Hodgkin lymphoma.
Zuo M; Shen H; Yin J; Wang W; Zhang Y; Zhou DB; Zhang W
Leuk Res; 2018 Jul; 70():56-61. PubMed ID: 29859415
[TBL] [Abstract][Full Text] [Related]
53. Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells.
Gricks CS; Zahrieh D; Zauls AJ; Gorgun G; Drandi D; Mauerer K; Neuberg D; Gribben JG
Blood; 2004 Dec; 104(13):4002-9. PubMed ID: 15161673
[TBL] [Abstract][Full Text] [Related]
54. Accumulation of vincristine and doxorubicin in malignant lymphocytes with different immunophenotypes.
Reizenstein P; Kapoor R; Gruber A; Peterson C
Eur J Haematol; 1989 Nov; 43(5):448-51. PubMed ID: 2693130
[TBL] [Abstract][Full Text] [Related]
55. [B cell subsets and the expression of CD40 in peripheral blood of patients with severe acute respiratory syndrome].
Wang C; Xia CQ;
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Oct; 26(10):590-3. PubMed ID: 14633439
[TBL] [Abstract][Full Text] [Related]
56. Gamma-radiation and mitomycin C sensitivity of peripheral blood lymphocytes from Saudi patients with non-Hodgkin's lymphoma.
Hannan MA; al-Sedairy ST; Gibson DP; McGarry TJ; Amer MH
Acta Haematol; 1990; 83(4):169-74. PubMed ID: 2115712
[TBL] [Abstract][Full Text] [Related]
57. Plasma phospholipid changes are associated with response to chemotherapy in non-Hodgkin lymphoma patients.
Cvetković Z; Milošević M; Cvetković B; Masnikosa R; Arsić A; Petrović S; Vučić V
Leuk Res; 2017 Mar; 54():39-46. PubMed ID: 28107691
[TBL] [Abstract][Full Text] [Related]
58. The role of the CD40 antigen on malignant B cells.
Planken EV; Willemze R; Kluin-Nelemans JC
Leuk Lymphoma; 1996 Jul; 22(3-4):229-35. PubMed ID: 8819071
[TBL] [Abstract][Full Text] [Related]
59. The activation-associated antigen 4F2 predicts patient survival in low-grade B-cell lymphomas.
Holte H; Davies CD; Kvaløy S; Smeland EB; Foss-Abrahamsen A; Kaalhus O; Marton PF; Godal T
Int J Cancer; 1987 May; 39(5):590-4. PubMed ID: 3106247
[TBL] [Abstract][Full Text] [Related]
60. [Abnormal Expression and Clinical Significance of B Lymphocyte Stimulating Factor in B Cell-derived Malignant Hematologic Diseases].
Han XL; Zhang XY; Li JD; Wang WL; Yang C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):138-141. PubMed ID: 28245390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
